Huidagene

1 known investors

HuidaGene Therapeutics is a gene therapy company developing CRISPR-based treatments across R&D pipelines targeting neurology, ophthalmology, and neuromuscular diseases, including MECP2 Duplication Syndrome, Huntington's Disease, ALS, and inherited retinal dystrophies. Its programs include first-in-human clinical trials for genetic disorders.

BiotechDeep TechHealthtech